Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $32,788 | 15 | 36.6% |
| Consulting Fee | $32,387 | 15 | 36.2% |
| Food and Beverage | $13,953 | 225 | 15.6% |
| Travel and Lodging | $8,827 | 26 | 9.9% |
| Unspecified | $1,550 | 6 | 1.7% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $53,611 | 111 | $0 (2021) |
| ABBVIE INC. | $13,536 | 26 | $0 (2024) |
| MERZ NORTH AMERICA, INC. | $12,728 | 54 | $0 (2020) |
| Merz Pharmaceuticals, LLC | $4,334 | 33 | $0 (2024) |
| Ipsen Biopharmaceuticals, Inc | $2,092 | 24 | $0 (2023) |
| Ipsen Pharma SAS | $673.64 | 3 | $0 (2019) |
| Alexion Pharmaceuticals, Inc. | $555.63 | 7 | $0 (2020) |
| Medtronic USA, Inc. | $277.33 | 3 | $0 (2019) |
| Piramal Critical Care | $250.84 | 2 | $0 (2018) |
| US WorldMeds, LLC | $220.92 | 2 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,094 | 5 | Merz Pharmaceuticals, LLC ($2,682) |
| 2023 | $8,866 | 25 | ABBVIE INC. ($7,897) |
| 2022 | $6,357 | 25 | ABBVIE INC. ($5,208) |
| 2021 | $16,545 | 25 | Allergan, Inc. ($15,947) |
| 2020 | $5,982 | 23 | MERZ NORTH AMERICA, INC. ($4,369) |
| 2019 | $26,185 | 82 | Allergan Inc. ($17,292) |
| 2018 | $10,086 | 39 | Allergan Inc. ($8,663) |
| 2017 | $12,387 | 63 | Allergan Inc. ($10,473) |
All Payment Transactions
287 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/22/2024 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $110.89 | General |
| Category: Musculoskeletal | ||||||
| 08/22/2024 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $20.78 | General |
| Category: Musculoskeletal | ||||||
| 06/26/2024 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,475.00 | General |
| Category: Musculoskeletal | ||||||
| 05/21/2024 | ABBVIE INC. | BOTOX (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $412.50 | General |
| Category: NEUROSCIENCE | ||||||
| 02/07/2024 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $74.85 | General |
| Category: Musculoskeletal | ||||||
| 12/14/2023 | Horizon Therapeutics plc | UPLIZNA (Drug) | Food and Beverage | In-kind items and services | $96.51 | General |
| Category: UPLIZNA | ||||||
| 12/06/2023 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $26.06 | General |
| Category: Musculoskeletal | ||||||
| 10/11/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $108.32 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/18/2023 | Dynasplint Systems Inc. | Dynasplint (Device) | Food and Beverage | In-kind items and services | $10.41 | General |
| Category: DME | ||||||
| 09/14/2023 | Ipsen Biopharmaceuticals, Inc | Dysport (Drug) | Food and Beverage | In-kind items and services | $141.12 | General |
| Category: Neurology | ||||||
| 09/11/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $20.03 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/06/2023 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $77.36 | General |
| Category: Musculoskeletal | ||||||
| 08/02/2023 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $138.00 | General |
| Category: Musculoskeletal | ||||||
| 07/26/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: FACIAL AESTHETICS | ||||||
| 04/20/2023 | ABBVIE INC. | BOTOX (Biological) | Consulting Fee | Cash or cash equivalent | $3,300.00 | General |
| Category: FACIAL AESTHETICS | ||||||
| 04/20/2023 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $20.13 | General |
| Category: Musculoskeletal | ||||||
| 04/14/2023 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $2,475.00 | General |
| 04/14/2023 | ABBVIE INC. | — | Travel and Lodging | In-kind items and services | $91.07 | General |
| 03/24/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $16.94 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 03/17/2023 | ABBVIE INC. | BOTOX (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $550.00 | General |
| Category: NEUROSCIENCE | ||||||
| 03/11/2023 | ABBVIE INC. | BOTOX (Biological) | Travel and Lodging | In-kind items and services | $557.97 | General |
| Category: FACIAL AESTHETICS | ||||||
| 03/11/2023 | ABBVIE INC. | BOTOX (Biological) | Travel and Lodging | In-kind items and services | $440.45 | General |
| Category: FACIAL AESTHETICS | ||||||
| 03/11/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $66.03 | General |
| Category: FACIAL AESTHETICS | ||||||
| 03/11/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $53.93 | General |
| Category: FACIAL AESTHETICS | ||||||
| 03/11/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $51.44 | General |
| Category: FACIAL AESTHETICS | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF NT 201 IN THE TREATMENT OF LOWER LIMB SPASTICITY CAUSED BY STROKE OR TRAUMATIC BRAIN INJURY IN ADULT SUBJECTS, FOLLOWED BY AN OPEN LABEL EXTENSION WITH OR WITHOUT COMBINED UPPER LIMB TREATMENT | MERZ NORTH AMERICA, INC. | $1,550 | 6 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 352 | 783 | $1.0M | $41,796 |
| 2022 | 9 | 304 | 620 | $816,689 | $32,310 |
| 2021 | 11 | 295 | 602 | $611,105 | $35,273 |
| 2020 | 10 | 285 | 548 | $498,008 | $32,556 |
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 40 | 134 | $65,392 | $11,925 | 18.2% |
| 64644 | Injection of chemical for paralysis of nerve muscles on arm or leg, 5 or more muscles, first extremity | Facility | 2023 | 44 | 93 | $190,836 | $6,931 | 3.6% |
| 64643 | Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, each additional extremity | Facility | 2023 | 54 | 133 | $252,833 | $6,242 | 2.5% |
| 64616 | Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | Facility | 2023 | 33 | 71 | $177,084 | $6,085 | 3.4% |
| 64642 | Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, first extremity | Facility | 2023 | 34 | 64 | $121,664 | $4,187 | 3.4% |
| 95874 | Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | Facility | 2023 | 102 | 220 | $113,285 | $2,921 | 2.6% |
| 64646 | Injection of chemical for paralysis of nerve muscles on trunk, 1-5 muscles | Facility | 2023 | 20 | 32 | $63,808 | $1,585 | 2.5% |
| 64645 | Injection of chemical for paralysis of nerve muscles on arm or leg, 5 or more muscles, each additional extremity | Facility | 2023 | 11 | 18 | $36,936 | $1,034 | 2.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 14 | 18 | $4,338 | $886.50 | 20.4% |
| 64616 | Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | Facility | 2022 | 27 | 64 | $167,872 | $6,279 | 3.7% |
| 64644 | Injection of chemical for paralysis of nerve muscles on arm or leg, 5 or more muscles, first extremity | Facility | 2022 | 41 | 76 | $151,392 | $5,955 | 3.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 34 | 72 | $34,128 | $5,564 | 16.3% |
| 64643 | Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, each additional extremity | Facility | 2022 | 43 | 113 | $208,598 | $5,537 | 2.7% |
| 64642 | Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, first extremity | Facility | 2022 | 27 | 53 | $97,838 | $3,448 | 3.5% |
| 95874 | Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | Facility | 2022 | 89 | 185 | $92,500 | $2,581 | 2.8% |
| 64646 | Injection of chemical for paralysis of nerve muscles on trunk, 1-5 muscles | Facility | 2022 | 16 | 29 | $56,144 | $1,402 | 2.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 14 | 15 | $5,175 | $988.68 | 19.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 13 | 13 | $3,042 | $555.51 | 18.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 44 | 161 | $74,060 | $12,645 | 17.1% |
| 64644 | Injection of chemical for destruction of nerve muscles on one arm or leg, 5 or more muscles | Facility | 2021 | 29 | 65 | $125,710 | $5,065 | 4.0% |
| 64643 | Injection of chemical for destruction of nerve muscles on arm or leg, 1-4 muscles, each additional extremity | Facility | 2021 | 34 | 88 | $157,696 | $4,164 | 2.6% |
| 64642 | Injection of chemical for destruction of nerve muscles on one arm or leg, 1-4 muscles | Facility | 2021 | 27 | 43 | $77,056 | $3,068 | 4.0% |
| 64616 | Injection of chemical for destruction of nerve muscles on one side of neck excluding voice box accessed through the skin | Facility | 2021 | 20 | 33 | $74,816 | $3,038 | 4.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 16 | 17 | $12,461 | $2,586 | 20.8% |
| 95874 | Needle measurement and recording of electrical activity of muscles for guidance with injection of chemical for destruction of muscles | Facility | 2021 | 71 | 139 | $67,415 | $1,995 | 3.0% |
About Dr. Erin Mcgonigle, M.D
Dr. Erin Mcgonigle, M.D is a Physical Medicine & Rehabilitation healthcare provider based in Milwaukee, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/16/2011. The National Provider Identifier (NPI) number assigned to this provider is 1740575828.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Erin Mcgonigle, M.D has received a total of $89,504 in payments from pharmaceutical and medical device companies, with $3,094 received in 2024. These payments were reported across 287 transactions from 24 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($32,788).
As a Medicare-enrolled provider, Mcgonigle has provided services to 1,236 Medicare beneficiaries, totaling 2,553 services with total Medicare billing of $141,935. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Practice Information
- Specialty Physical Medicine & Rehabilitation
- Other Specialties Physical Medicine & Rehabilitation
- Location Milwaukee, WI
- Active Since 06/16/2011
- Last Updated 02/20/2018
- Taxonomy Code 208100000X
- Entity Type Individual
- NPI Number 1740575828
Products in Payments
- BOTOX (Biological) $39,857
- BOTOX (Drug) $17,292
- XEOMIN (Biological) $12,600
- Xeomin (Biological) $4,462
- BOTOX NEURO REHAB (Drug) $3,675
- DYSPORT (Drug) $1,638
- Dysport 300 U-1 (Drug) $605.77
- Dysport (Drug) $521.76
- SOLIRIS (Drug) $431.74
- BOTOX THERAPEUTIC (Biological) $365.68
- GABLOFEN 1 mL in 1 SYRINGE, GLASS (Drug) $250.84
- BOTOX - NEUROLOGY (Drug) $188.54
- SYNCHROMED (Device) $185.14
- Exparel (Drug) $153.28
- NAMZARIC (Drug) $145.53
- Soliris (Drug) $123.89
- MYOBLOC (Biological) $119.20
- OCREVUS (Biological) $119.02
- NORTHERA (Drug) $104.64
- Xadago (Drug) $101.72
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physical Medicine & Rehabilitation Doctors in Milwaukee
Dr. Nicholas Ketchum, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $640,689
Mr. Christopher Cronsell, Md, MD
Physical Medicine & Rehabilitation — Payments: $415,633
Dr. John Mcguire, Md, MD
Physical Medicine & Rehabilitation — Payments: $90,251
Dr. Brian Robertson-Dick, Md, MD
Physical Medicine & Rehabilitation — Payments: $69,100
Bindiya Shah, Do, DO
Physical Medicine & Rehabilitation — Payments: $9,988
Carla Wright, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $8,127